0830 GMT - Bayer's fourth-quarter results are slightly ahead of expectations and guidance is in line with consensus, but the free cash flow outlook is soft, Jefferies analysts write. Bayer reported fourth-quarter adjusted Ebitda of 2.35 billion euros versus consensus at 2.27 billion euros while free cash flow also beat views. Full-year 2025 guidance for Ebitda of 9.3 billion-9.8 billion euros at closing exchange rates compares to consensus at 9.4 billion euros while core EPS guidance is also ahead. But free cash-flow guidance of 1.3 billion-2.3 billion euros is below the 2.8 billion euros expected by consensus. "We expect a small negative response." Shares rise 1.5% after initially dropping as much as 2.5% at the open. (dominic.chopping@wsj.com)
(END) Dow Jones Newswires
March 05, 2025 03:30 ET (08:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.